Open Access

A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility

  • Ryan W. O’Meara1, 2,
  • Sarah E. Cummings1, 2,
  • John-Paul Michalski1, 2 and
  • Rashmi Kothary1, 2, 3, 4Email author
BMC Neuroscience201617:7

https://doi.org/10.1186/s12868-016-0242-2

Received: 23 July 2015

Accepted: 24 January 2016

Published: 1 February 2016

Abstract

Background

The decline of remyelination in chronic multiple sclerosis (MS) is in part attributed to inadequate oligodendrocyte precursor cell (OPC) migration, a process governed by the extracellular matrix (ECM). Elucidating the mechanisms underlying OPC migration is therefore an important step towards developing new therapeutic strategies to promote myelin repair. Many seminal OPC culture methods were established using rat-sourced cells, and these often need modification for use with mouse OPCs due to their sensitive nature. It is of interest to develop mouse OPC assays to leverage the abundant transgenic lines. To this end, we developed a new OPC migration method specifically suited for use with mouse-derived cells.

Results

To validate its utility, we combined the new OPC migration assay with a conditional knockout approach to investigate the role of integrin-linked kinase (ILK) in OPC migration. ILK is a focal adhesion protein that stabilizes cellular adhesions to the extracellular matrix (ECM) by mediating a linkage between matrix-bound integrin receptors and the cytoskeleton. We identified ILK as a regulator of OPC migration on three permissive substrates. ILK loss produced an early, albeit transient, deficit in OPC migration on laminin matrix, while migration on fibronectin and polylysine was heavily reliant on ILK expression.

Conclusions

Inclusively, our work provides a new tool for studying mouse OPC migration and highlights the role of ILK in its regulation on ECM proteins relevant to MS.

Keywords

Mouse oligodendrocyte precursor cells Migration Integrin-linked kinase Extracellular matrix Laminin Fibronectin Polylysine

Background

Oligodendrocytes (OLs) are responsible for generating myelin, a lipid-rich structure that envelops central nervous system (CNS) axons, allowing for rapid communication between neurons. OLs generate myelin as they differentiate by extending multiple processes that contact adjacent axons, forming concentric wrappings of lipid-rich OL membrane mostly devoid of cytoplasm and stabilized by myelin structural proteins [1]. Prior to the onset of myelination, newborn OL precursor cells (OPCs) undergo a transient period of local proliferation followed by migration [2], their direction and extent governed by patterning molecules. Proper myelination is therefore highly dependent on the capacity of OPCs to migrate to target destinations and initiate the differentiation program. As such, researchers have endeavored to dissect the extracellular cues and the intracellular machinery governing OPC migration. This is especially relevant in neurological diseases like multiple sclerosis (MS) where the capacity for endogenous repair may be limited partly by the hampered migration of OPCs into lesions [3].

Over the years, our understanding of OL biology has vastly improved through the study of rat OLs in vitro, for which several isolation methods exist [46]. However, these strategies are often not ideal for isolating mouse OPCs for a number of reasons. First and foremost, mice possess fewer OPCs due to their smaller size. Primary mouse OPCs are also more difficult to isolate when compared to rat OPCs (reviewed by [7], and are less viable in vitro [8]). As such, researchers have endeavored to modify existing rat OPC protocols/assays to allow for their use with mouse-derived cells [7, 911] to take advantage of the broad spectrum of transgenic mouse lines.

We were interested in developing a mouse-optimized assay for studying OPC migration in vitro. Traditionally, OPC migration was typically assessed with the “transwell” or “agarose drop” assays [12]. The transwell assay [13] measures cell migration through a porous membrane, whereas the agarose drop assay [14] measures radial migration out of a drop of low-melting temperature agarose. While effective with rat cells, certain aspects of these assays limit their applicability to mouse OPCs. In particular, the agarose drop assay calls for relatively long assay durations (days), which does not appease the limited viability of mouse OPCs. Both protocols also call for large numbers of OPCs, which are laborious to obtain from mice, thereby fuelling us to devise a method for assessing mouse OPC migration that is rapid and requires few cells.

We previously established a protocol for isolating mouse OPCs [9], and as a byproduct of the procedure, OPCs tend to form aggregates (henceforth termed OPCAs) suspended in the culture media. We show that a highly enriched population of OPCs efficiently emerges from OPCAs, and describe a method to quantifiably assess this phenomenon. By combining the OPCA assay with conditional knockout genetics, we reveal a role for the focal adhesion protein integrin-linked kinase (ILK) in OPC migration on three substrates. Inclusively, we provide a new tool for the study of mouse OPC motility in vitro, and validate its utility through use in identifying ILK as a mediator of OPC migration.

Methods

Transgenic animals

Animals used for this work were cared for according to the Canadian Council on Animal Care guidelines under University of Ottawa Animal Care Committee protocol number OGH-130. The floxed Ilk mouse line (Ilk fl/fl ; [15]) was graciously provided by Dr. René St-Arnaud (McGill University, Montreal, Canada). Ilk fl/fl mice were subsequently bred to homozygosity with the mT/mG reporter mouse strain [16] to yield the Ilk fl/fl ; mT/mG line.

Cell culture

OPCAs were generated as a byproduct of the mouse OPC purification protocol previously described by us [9]. Neonatal mouse cortices were dissociated and seeded into poly-l-lysine coated T25 flasks in mixed glial culture media. Once cultures had achieved appropriate density, the flasks first underwent rotary shaking utilizing a VWR Advanced 3500 Orbital Shaker (0.75 inch orbit) at low speed (50 rpm) for 1 h to remove contaminating microglia. Fresh mixed culture media was added back to the cultures, which were then shaken at a speed of 220 rpm overnight (approximately 16 h), to generate suspended clumps of OPCs (OPCAs). The media was passed through a 40 µm cell strainer and the OPCAs were subsequently backwashed onto sterile Petri dishes (Fig. 1a–c). OPCAs were picked from the Petri dish with a P20 pipette by aid of a stereomicroscope, and seeded individually onto substrate-coated coverslips in migration or differentiation media (see below). Coverslips were coated with either human placental merosin (laminin; 10 µg/mL; Millipore), fibronectin (50 µg/mL; Calbiochem) or >300,000 molecular weight poly-d-lysine (0.1 mg/mL; Sigma-Aldrich).
Fig. 1

Pictorial demonstration on how to obtain OPCAs from cell suspensions. a The cell suspension collected from shaken mixed glial cultures is gently added to a 40 µm cell strainer over a 50 mL conical tube. b The strainer is then flipped upside-down and placed over a new 50 mL conical tube. c Migration media is used to backwash the strainer, causing the transfer of the OPCAs to the conical tube. d An image obtained through the eyepiece of a stereomicroscope, showing freshly isolated OPCAs. When selecting OPCAs for migration experiments, it is desirable to select those most uniform in dimension, such as the one denoted by the black arrow

Cell culture media

Mixed glial culture media was Dulbecco’s modified eagle medium (DMEM) supplemented with 1 % GlutaMAX (Life Technologies), 10 % fetal bovine serum (FBS), 0.33 % Penicillin–Streptomycin (P/S). From culture day 6 and onwards, the mixed glial culture media was supplemented with 5 µg/mL insulin.

Migration media was composed of 48–72 h conditioned mixed glial culture media (0.22 µm filtered), supplemented with 2 % B27 (Gibco), 100 µg/mL bovine serum albumin (BSA), 5 µg/mL insulin, 0.5 µg/mL Holo-transferrin, 60 ng/mL progesterone, 400 ng/mL 3,3′,5-triiodo-l-thyronine, 400 ng/mL l-thyroxine, 16 µg/mL putrescine, 5 ng/mL sodium selenite, 10 ng/µL platelet-derived growth factor (PDGF-AA; PeproTech), 50 ng/µL ciliary neurotrophic factor (CNTF; Peprotech) and 1 µg/mL aphidicolin (Sigma-Aldrich).

Conditional genetic ablation

In vitro recombination of the Ilk fl/fl and mT/mG alleles was achieved by treating mixed glial cultures with recombinant His-TAT (trans-activator of transcription)-NLS (nuclear localization sequence)-Cre recombinase (henceforth called TAT-Cre; Excellgen Incorporated). Briefly, the media was removed and the cultures were washed with PBS. TAT-Cre (or the corresponding vehicle control) was administered at 10 µL/mL in DMEM with 2 % B27 and incubated on the cultures for 1–2 h. This treatment was performed twice 48–72 h prior to OPCA isolation to promote a high level of recombination.

Immunostaining and microscopy

OPCAs were fixed with 3 % paraformaldehyde (PFA) and then either processed for indirect immunofluorescence microscopy, or mounted onto slides in DAKO medium after staining with Hoechst.

For indirect immunofluorescence, fixed OPCAs were permeabilized with 0.1 % Triton X-100 for 10 min at room temperature (RT), and washed with PBS. OPCAs were blocked with 10 % goat serum, and incubated overnight at 4 °C with primary antibodies against Olig2 (EMD Millipore) or PDGFR-α (provided by Dr. William Stallcup, Sanford Burnham Medical Research Institute, La Jolla, California). The following day, the samples were washed with PBS and incubated with Alexa fluor-conjugated secondary antibodies (invitrogen) for 45 min to 1 h at RT. Coverslips were subsequently washed with PBS, counterstained with Hoechst and mounted onto slides in DAKO medium.

Standard epifluorescent images were acquired with an Axio Imager M1 microscope equipped with an AxioCamHR HRm Rev.2 camera using EX Plan-Neofluar 10x/0.3 Ph1 or Fluar 5x/0.25 M27 objectives and Axiovision 4.8.2 software. Confocal microscopy was conducted with a Zeiss LSM 510 Meta DuoScan microscope using EC Plan-Neofluar 10×/0.3 M27, 20×/0.5 M27, 40×/1.3 Oil DIC M27 or Plan-Apochromat 63×/1.4 Oil DIC M27 objectives and Zen 8.0 software.

Phase contrast microscopy was performed with an Axiovert 200 M microscope fitted with an AxioCamHR HRm Rev.2 camera using LD Plan Neofluar 20×/0.4 Korr Ph2 or EC Plan-Neofluar 10×/0.25 Ph1 objectives and Axiovision 4.6 software.

Migration quantification

Phase contrast images of OPCAs were acquired at time zero to record their original diameter. Migration assays were fixed at 4, 10 or 24 h and imaged by fluorescence microscopy. Using Photoshop, “exclusion zones” were digitally overlaid onto the residual OPCA core, serving to define the starting point of migration; only cells beyond the exclusion zone were considered to have truly migrated. For OPCAs seeded on laminin and fibronectin substrates, the size of the exclusion zone was 1.5 × the OPCA diameter at time zero. For the poly-d-lysine substrate, the exclusion zone was 1.75×, 2.0× and 2.75× the time zero OPCA diameter for 4, 10 and 24 h time points, respectively.

Concentric rings were then digitally centered over the exclusion zone, their diameter increment being 50, 100 and 200 µm for 4, 10 and 24 h time points for assays conducted on laminin. For the fibronectin substrate, the ring diameter increment was 20, 40 and 80 µm for the 4, 10 and 24 h time points, respectively. For the poly-d-lysine substrate, the ring increment for the 4, 10 and 24 h time points was 10, 20 and 40 µm, respectively. The number of OPCs that migrated to each concentric ring was quantified and represented as the percentage of OPCs in each ring. This can be considered a measure of migration distance or be represented as the total number of migrated OPCs, regardless of distance. We interpret this latter parameter as a function of the cell to initiate migration or polarize.

Immunoblot

Mixed glial cultures were cooled on ice for 3 min, rinsed with ice cold PBS, and scraped into a commercial RIPA lysis buffer (cell signaling) supplemented with 2 mM PMSF. Lysates were left on ice for approximately 2 min, and centrifuged at 15,000 rpm for 5 min. Clarified lysates were transferred to new microfuge tubes and stored at −80 °C.

For SDS-PAGE, 30 µg of cell lysate per sample was resolved on a poly-acrylamide gel, and transferred to a PDVF membrane at 0.25 amps for 70 min. Membranes were blocked for approximately 1 h at RT with 5 % skim milk power in TBST (10 mM Tris–HCl pH 8.0, 150 mM NaCl, 0.1 % Tween-20). Primary antibodies against ILK (cell signaling) and GAPDH (Abcam) were incubated overnight in blocking buffer. Membranes were washed with TBST and probed with HRP-conjugated secondary antibody for 45 min. Membranes were then washed with PBS, and treated with ECL (Thermo Scientific). Resulting films were scanned with an EPSON Perfection 2450 PHOTO scanner, imported into ImageJ, and a box of standard dimensions was placed over each band to measure the mean gray value. Densitometric values for ILK were normalized to GAPDH as a loading control.

Statistical analysis

One “n” (i.e., experiment) was considered as data obtained from pooled biological material (i.e., cells) from mouse pups (usually 4–6) of a distinct litter. Differences in migration distance were assessed using two-way repeated measures ANOVA paired with Bonferroni multiple comparisons tests. All other data was tested using either unpaired two-tailed Student’s t tests or one-way ANOVA paired with Bonferroni multiple comparisons tests. For all statistical tests, “n” was equal to or greater than three, and differences in the mean were considered significant when p < 0.05.

Results

An assay for investigating mouse OPC migration in vitro

In 1980, McCarthy and DeVellis published a seminal paper describing the isolation and propagation of primary rat OPCs in mixed glial cultures. In this method, neonatal cortical tissue is dissociated into a single cell suspension and seeded into tissue culture flasks. Over several days, astrocytes form a monolayer on the base of the flask, upon which OPCs proliferate. The OPCs are relatively loosely attached to this monolayer, and are susceptible to separation when flasks are shaken on an orbital rotator overnight at 37 °C. This procedure renders the suspension of OPCs in the culture medium, many of which form aggregates (OPCAs) due to their innate tendency to do so [12].

In our mouse adaptation of the McCarthy and deVellis method [9], we took advantage of this aggregation phenomenon to assess OPC migration. After the overnight shaking step, the medium containing the OPCAs was filtered through a 40 μm cell strainer, and then backwashed with migration media into a 50 mL conical tube (Fig. 1a–c). The backwashed media was then transferred to a Petri dish, and OPCAs were picked with a micropipette by aid of a stereomicroscope. As a result of the mechanism of their formation, OPCAs can be heterogeneous in shape, and care was taken in selecting the most uniform aggregates for migration experiments (Fig. 1d).

Once selected, OPCAs were seeded individually onto substrate-coated coverslips in 48–72 h conditioned mixed glial culture media supplemented with various OL survival factors (see “Methods” for details). The purpose of this media was to favor the maintenance of OPCs in a precursor state, as migration generally ceases in differentiated OLs. We also aimed to control OPC proliferation by including aphidicolin (mitotic inhibitor) in the migration media, as excessive proliferation could give the false impression of extensive migration.

When seeded onto laminin-coated coverslips, large numbers of cells migrated out of OPCAs over a 24 h period (Fig. 2a). After a given experimental duration (e.g., 10 h), OPCAs were processed for immunofluorescence microscopy, and concentric rings (centered on the OPCA core) were digitally overlaid on the acquired images (Fig. 2b). When OPCs in each concentric ring were counted, distributions could be generated that described the net distance traveled by the cells over a given timeframe. Slow migration rate would cause OPCs to appear accumulated in rings proximal to the OPCA core, whereas efficient migration would increase the proportion of cells in the more distal rings. This data could also be portrayed as the total number of migrated OPCs (regardless of distance), which we interpret as a measure of migration initiation. For example, a reduction in the total number of migrating OPCs subsequent to an experimental manipulation could be interpreted as compromised migration initiation.
Fig. 2

Seeding OPCAs on migration-permissive substrates yields a quantitative means to assess OPC motility. a Time-lapse phase contrast microscopy of an OPCA from which OPCs emerge radially over a 24 h period. b A 10 h migrated OPCA before (i) and after (i’) superimposing concentric rings (100 µm increments) over the residual OPCA core (solid white circle). Migration distance can be conveyed as the proportion of cells in each ring or the total number of migrated cells regardless of distance. Membrane-targeted tdTomato (red) facilitates visualization of cell bodies. Scale bar, a 50 µm

To ensure that migratory cells were in fact OPCs, OPCAs were labeled with antibodies against the OPC markers platelet-derived growth factor receptor-α (PDGFR-α) and Olig2 (reviewed by [17]). Preliminary observations suggested the majority of cells were immunopositive for these markers (Fig. 3a), and subsequent quantification revealed that 88.6 % (±0.4 %) were in fact Olig2+ (Fig. 3b). Our observations indicate the majority of cells migrating from OPCAs are of OL-lineage, thereby validating the utility of this assay for studying OPC migration.
Fig. 3

OPCAs are predominantly composed of OPCs. a 10 h migrated OPCAs showing the majority of migratory cells are positive for the OPC markers PDGFR-α and Olig2. b OPCAs are composed of on average 88.6 % (±0.4 %) Olig2+ cells. Data represent the mean ± SEM (n = 3). Scale bars, a 50 and 20 µm (inset)

Conditional ablation of ILK from OPCAs

Subsequent to its validation, we aimed to utilize the OPCA assay to investigate the role of ILK in mouse OPC migration. ILK is a focal adhesion protein that elicits its function via interaction with the integrins, a family of transmembrane receptors that mediate adhesion to the ECM. During migration, integrin receptors cluster in discrete foci at the leading edge of lamellipodia, forming cell/matrix contacts that are used as anchor points for the actin cytoskeleton. Integrins are heterodimers composed of an α and a β subunit, and OL-lineage cells express αvβ1, αvβ3, αvβ5, αvβ8 and α6β1 integrins inclusively [18]. ILK binds to the intracellular tails of β1 and β3 integrin subunits [19, 20], and plays both signaling and scaffolding roles at actin-integrin connections (Fig. 4a; [21, 22]. ILK performs these functions with help from binding partners PINCH and parvin, which respectively link ILK to receptor tyrosine kinases and the actin cytoskeleton [23]. In OLs, ILK mediates cellular morphology by way of regulating actin architecture and the activity of the cytoskeletal remodeling protein RhoA [24, 25]. As cellular motility relies on Rho-GTPase signaling, cytoskeletal dynamics and morphological plasticity, we hypothesized that ILK is required for ECM-directed OPC migration.
Fig. 4

Conditional genetic ablation of Ilk from OPCAs. a ILK is a focal contact protein that links ECM-bound integrin receptors to the actin cytoskeleton via its partner parvin. In the depiction, α6β1 and αvβ3 integrin receptors reside at the leading edge of a migrating OPC’s process, where they respectively bind laminin (Ln) and fibronectin (Fn). At the β-integrin cytosolic tails, ILK stabilizes ECM adhesions to the actin cytoskeleton (red circles) by acting as a scaffold. b Schematic representation of the mouse Ilk fl/fl locus, where Cre recombination excises exons 5–12 of the Ilk gene [15]. c Schematic representation of the mT/mG reporter locus [16]. Cre-recombination at the LoxP sites excises tdTomato and induces EGFP expression. d Western blot showing TAT-Cre reduces ILK protein when administered to Ilk fl/fl ;mT/mG cultures. Significant difference confirmed by densitometric analysis. e OPCAs isolated from TAT-Cre treated Ilk fl/fl ;mT/mG cultures, showing they are composed of both recombined (EGFP-positive) and non-recombined (tdTomato-positive) OPCs. Presumably, ILK is depleted from OPCs expressing EGFP. For d, data represent the mean ± SEM (n = 3), *p < 0.05 (Student’s t test). Scale bar, 50 μm

To this end, we employed a mutant mouse possessing loxP sites flanking exons 5–12 of the endogenous Ilk gene (Ilk fl/fl ; Fig. 4b), where recombination presumably produces null alleles [15]. We then bred Ilk fl/fl ;mT/mG double transgenics by crossing Ilk fl/fl mice with the mT/mG strain; a reporter line harboring a locus coding for near-ubiquitous expression of the fluorescent protein tdTomato [16]. The action of Cre recombinase at this locus ablates tdTomato, while at the same time inducing EGFP (Fig. 4c), thereby permitting identification of Cre-recombined cells. Therefore, recombined cells should express EGFP and be devoid of ILK, while non-recombined cells remain tdTomato+ and retain ILK expression.

Mixed glial cultures were then established from Ilk fl/fl ;mT/mG mice and treated with cell-permeable TAT-Cre recombinase or vehicle control (see “Methods” for details). As expected, TAT-Cre administration led to a reduction in total ILK protein in Ilk fl/fl ;mT/mG cultures as compared with vehicle-treated controls (Fig. 4d). We then isolated OPCAs from TAT-Cre treated cultures and allowed OPCs to migrate outwards for 10 h. Cre-recombined OPCs could be identified by their expression of EGFP, although non-recombined (tdTomato+) OPCs were still a significant component of the TAT-Cre treated OPCA (Fig. 4e). In sum, our work shows that the OPCA assay can be used in conjunction with conditional knockout genetics, and we next aimed to utilize this strategy to investigate the role of ILK in OPC migration.

Loss of ILK mildly impairs OPC migration on laminin

Merosin, a blanket term for α2-chain containing laminin (Ln) proteins (Ln-2, Ln-4 and Ln-13; [26] influences various aspects of OL biology including growth factor-mediated survival [27, 28], morphological development [29], and CNS myelination [24]. Notably, myelinating CNS white matter tracts express the Ln α2-chain [30, 31], which is also upregulated after experimentally induced demyelination [32]; reviewed by [33]. In addition, Ln promotes OPC migration [3436], rendering Ln signaling pathways appealing pharmacological targets for overcoming the inhibitory barriers impeding OPC infiltration into MS lesions.

Ln binds the α6β1 integrin expressed by OLs [29], triggering ILK recruitment to β1-cytosolic tails [23], yielding Ln-α6β1-ILK complexes to which the actin cytoskeleton is stabilized. These adhesions presumably act as ECM anchor points that transmit cytoskeletal contractile forces during cellular migration. We therefore hypothesized that ILK loss would impede OPC migration on Ln due to actin-integrin disassociation. To this end, TAT-Cre treated and vehicle treated Ilk fl/fl ;mT/mG OPCAs (henceforth referred to as Ilk / and Ilk fl/fl OPCAs respectively) were seeded onto Ln substrates, allowing migration to occur for 4, 10 and 24 h. Using concentric ring quantification, we found that ILK loss caused an accumulation of OPCs in the 50 μm proximal ring after 4 h compared to Ilk fl/fl OPCAs. Additionally, there was a corresponding decrease in the proportion of Ilk / OPCs that had attained the more distal 100 μm ring, ultimately indicating a reduction in net migration distance (Fig. 5a, b). Interestingly, this deficit was not evident at 10 or 24 h. There was also a near-significant trend for fewer total migrated Ilk / OPCs at the 4 h time point (p = 0.0675; Fig. 5c), an indication of reduced capacity to initiate migration. Importantly, there was no difference between the diameters of Ilk / and Ilk fl/fl OPCAs at seeding, discounting size as a confounding variable in our observations (Fig. 5d). Rather, we attribute our findings to a role for ILK in the initiation and/or maintenance of migration on Ln.
Fig. 5

Transient impairment of OPC migration on laminin in response to ILK loss. a Representative confocal images of Ilk / and Ilk fl/fl OPCAs migrated on Ln for 4, 10 and 24 h. b Quantification of OPC migration using the concentric ring method (see “Methods” section). At the 4 h time point, Ilk / OPCs accumulated in the most proximal concentric ring (50 μm) and fewer attained the more distant 100 μm ring as compared to Ilk fl/fl control cells. Interestingly however, Ilk / and Ilk fl/fl OPCs migrated to the same extent at the 10 and 24 h time points. c No significant difference between the total number of migrated Ilk / and Ilk fl/fl OPCs was found at any time point. d There was no significant difference in initial diameter of Ilk / and Ilk fl/fl OPCAs. Data represent the mean ± SEM (n = 5, 5 and 4 for the 4, 10 and 24 h time points, respectively). For b, *p < 0.05; ****p < 0.0001 (repeated measures two-way ANOVA followed by Bonferroni post-tests). For c and d, data was tested with Student’s t test. Scale bars, 50, 100 and 200 μm for 4, 10 and 24 h time points, respectively

ILK loss severely disrupts OPC migration on fibronectin

Fibronectin (Fn) is a migration-permissive substrate for OPCs [34, 37], but evidence suggests that Fn aggregation impedes remyelination in MS [38]. This underscores the importance of elucidating the signaling pathways that govern OPC migration on Fn, as their pharmacological manipulation may influence the degree to which OPCs infiltrate MS lesions. OL-lineage cells express the αvβ1, αvβ3, αvβ5 and αvβ8 integrin receptors which recognize the Arg-Gly-Asp (RGD) integrin binding sequence intrinsic to Fn and other ECM molecules [37, 39]. As ILK is recruited to β1 and β3 integrin tails to stabilize actin at cell–matrix contacts, we hypothesized that ILK-depleted OPCs would suffer from defective migration on Fn substrates.

Ilk / and Ilk fl/fl OPCAs were seeded onto Fn-coated coverslips, and migration was assessed after 4, 10 and 24 h. In contrast to migration on Ln, there was no substantial OPC migration of either genotype on Fn at 4 h. Not surprisingly then, we noted no migration differences between Ilk / and Ilk fl/fl OPCs at this time point (Fig. 6a, b). Rather, we observed significantly reduced net migration distance of Ilk / OPCs at 10 and 24 h. At 10 h, Ilk / OPCs accumulated in the most proximal concentric ring (40 μm), with correspondingly fewer cells reaching the more distal ring (80 μm), a defect that persisted at 24 h. The total number of migrated Ilk / OPCs was also significantly reduced at 10 and 24 h (Fig. 6c), implying a role for ILK in initiating migration on Fn. We observed no significant difference in the size of Ilk fl/fl and Ilk / OPCAs at seeding time (Fig. 6e), excluding OPCA size as a factor in our analysis. Our data suggest OPC migration on Fn relies heavily on ILK, as its loss compromises both net migration distance and the initiation of migration itself.
Fig. 6

Loss of ILK perturbs OPC migration on fibronectin substrate. a Confocal micrographs of Ilk fl/fl and Ilk / OPCAs migrated on Fn for 4, 10 and 24 h. b Quantification revealed no difference in the distance migrated between Ilk / and Ilk fl/fl populations at 4 h. However, at 10 h, Ilk / OPCs predominantly migrated to the 40 μm proximal ring, and fewer reached the more distant 80 μm ring as compared to Ilk fl/fl cells. Similarly, at 24 h, Ilk / OPCs accumulated in the 80 μm proximal ring, with fewer attaining the more distal 160 μm ring. c There was no difference in the total number of migrated Ilk / and Ilk fl/fl OPCs at 4 h, while significantly fewer Ilk / OPCs had migrated at the 10 and 24 h time points. d The initial diameter of Ilk / and Ilk fl/fl OPCAs prior to assay commencement was not significantly different for any of the time intervals investigated. Data represent the mean ± SEM (n = 3). For b, *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 (repeated measures two-way ANOVA followed by Bonferroni post-tests). For c and d, *p < 0.05 (Student’s t test). Scale bars, 50 μm for 4 h, 100 μm for 10 and 24 h

ILK is required for OPC migration on polylysine matrix

Poly-d-lysine (PDL) is a molecule that carries a net positive charge and interacts with anionic cell membrane domains to mediate adhesion [40]. While polylysine itself does not mediate cell adhesion via the integrins [41], it can promote the deposition of cell culture media-borne proteins [42], some of which may activate integrins to regulate migration. PDL can be thought of as a substrate that provides both a non-specific charge-based affinity for cells, and one that facilitates veritable receptor-ligand interactions.

When migrated on PDL, Ilk / OPCs accumulated more so in the most proximal concentric rings at the 4, 10 and 24 h time points as compared to Ilk fl/fl cells (Fig. 7a, b). ILK depletion also yielded fewer total migrated OPCs at 4 h, although no significant difference was observed at 10 and 24 h (Fig. 7c). This early lag in emergence from the OPCA offers a role for ILK in the initiation of OPC migration on PDL, which does not persist at later time points. Importantly, no difference was observed in the initial OPCA diameters between genotypes (Fig. 7d), excluding size as a confounding factor in our analysis. Instead, our data support an intriguing function for ILK in the initiation and maintenance of OPC migration on a substrate that likely possesses a mixture of signaling cues.
Fig. 7

ILK mediates OPC migration on PDL. a Confocal images of Ilk / and Ilk fl/fl OPCAs migrated on PDL for 4, 10 and 24 h. b As compared to Ilk fl/fl OPCs, Ilk / OPCs were more concentrated in the 10, 20 and 40 μm proximal concentric rings at 4, 10 and 24 h respectively. c No difference in the total number of migrated Ilk / versus Ilk fl/fl OPCs was observed at 10 or 24 h, although significantly fewer Ilk / OPCs had migrated at the 4 h time point. d There was no difference in the diameters of Ilk / versus Ilk fl/fl OPCAs prior to commencement of the assay for any of the time points assessed. Data represent the mean ± SEM (n = 4). For b, **p < 0.01; ***p < 0.001 (repeated measures two-way ANOVA followed by Bonferroni post-tests). For c and d, **p < 0.01 (Student’s t test). Scale bars, 50 μm

Discussion

In this report, we demonstrate a role for ILK in OPC migration by utilizing a newly developed method tailored for mouse-derived cells. We show ILK regulates OPC migration on Ln and Fn, two ECM proteins present in demyelinated lesions [32, 38] as well as on a polylysine matrix. Impaired OPC infiltration into MS lesions is thought to partly underlie the lack of regeneration seen in chronic MS, emphasizing the need to understand the mechanics governing OPC migration, especially when pursuing remyelination therapies. Our work contributes to this increasing understanding, while also providing a new tool for investigating OPC migration that is amenable to both constitutive and conditional knockout/transgenic mouse lines.

An assay to study mouse OPC migration in vitro

The use of mouse OPCs in basic research is becoming increasingly popular, a trend surely reflecting the accessibility of mutant lines and technological advancements in their generation. However, when compared to rat-sourced cells, the utility of mouse OPCs is limited as they are more difficult to isolate [7] and do not survive as well in culture [8]. This imposes constraints on the commonly used “agarose drop” and “transwell” migration assays, emphasizing the need for methods that account for the shortcomings of mouse OPCs. We estimate that an OPCA is composed of approximately 300-1000 cells, and a typical preparation yields roughly 50–100 OPCAs. Additionally, migration can be measured in as little as 4 h rather than several days, as is the case for the agarose drop assay. Our assay therefore accommodates the limitations of mouse OPCs by calling for few cells and requiring relatively short assay durations.

Our method bears resemblance to the “oligosphere” assay, originally described by [5]. In this method, rat OPCs are purified using a Percoll gradient, and seeded onto uncoated tissue culture vessels. Over several days, suspended OPCs form spherical aggregates reminiscent of neurospheres, while their OL identity is maintained through use of N1 supplemented B104-conditioned media. When seeded onto polyornithine substrates, OPCs emerge from oligospheres in a radial fashion as in our OPCA assay. This method has been applied to elegantly demonstrate that polysialylation of neural cell adhesion molecule (PSA-NCAM) favours OPC migration [43], and been leveraged to identify the importance of metalloproteases in OPC migration on CNS matrices [44]. To modify the assay for use with mouse cells, [11] increased the concentration of insulin and progesterone in the oligosphere culture media to enhance OPC proliferation and/or ameliorate viability [11].

One major benefit of the OPCA assay over the oligosphere method is that aggregate generation requires less researcher manipulation. To generate OPC aggregates in the OPCA assay, mixed glial cultures are simply shaken on an orbital rotator overnight in a tissue culture incubator. To generate oligospheres however, multiple 18 h differential adhesion steps need be conducted [5]. Our method also describes an efficient means to conditionally ablate/modify genes using LoxP technology, which is of high value when investigating genes whose constitutive loss leads to embryonic lethality.

Another feature of the OPCA method is its potential use in live cell imaging, facilitating the observation of OPC migration in real-time. In our hands however, we have experienced phototoxicity as a result of visualizing fluorescent proteins (e.g., EGFP, tdTomato) in live OPCs (data not shown). In addition, live imaging may not be suitable when assessing the effect of photosensitive compounds on OPC migration.

ILK in OPC migration on various substrates

Interactions between the ECM and OL-bound integrin receptors govern numerous aspects of OL biology (reviewed by [9]. OPCs express the α6β1 integrin Ln receptor along with the αvβ1 and αvβ3 integrin Fn receptors [18], to which ILK binds at β1 and β3 cytoplasmic tails [19, 20]. The impaired migration of Ilk / OPCs on Ln and Fn matrices likely results from perturbed stability of connections between the ECM and the actin cytoskeleton (Fig. 4a). Disrupting these adhesion complexes would likely translate to difficulty stabilizing a leading process, and compromise the cell’s ability to utilize focal contacts to transduce cytoskeletal contractile forces required for migration.

Interestingly, ILK loss produced only a mild deficit in OPC motility on Ln, in that migration was lagging at 4 h, but had recovered at the 10 and 24 h time points. As ILK stabilizes α6β1 integrins on Ln, our findings are in agreement with previous studies showing a role for α6β1 integrin only during the early phases of OPC migration [39], with no significant contribution in the long term [37]. These data insinuate a more significant role for α6β1 integrin in other aspects of OL biology, as it is the major β1-type receptor expressed by OLs, and is consistently expressed throughout OL development [18]. Accordingly, extension of OL myelin membrane [29], and CNS myelination [45, 46] are regulated by Ln-α6β1 integrin interactions, while similar functions have been identified for ILK [24, 25]. The Ln-α6β1-ILK complex may therefore be more relevant in post-migratory OL development, while only mildly contributing to Ln-directed motility. The observation that efficient migration still occurred on Ln in the absence of ILK suggests alternate signaling mechanisms predominantly drive migration on this substrate.

We offer the possibility that OPCs express additional, ILK-independent receptors that contribute to OPC migration on Ln. Existence of such receptors could explain how Ilk / OPCs are only mildly incapacitated in their migration on Ln, and ultimately travel to the same degree as control cells. One candidate is dystroglycan, a Ln binding protein expressed by OL-lineage cells [47], with a function in OL process outgrowth [48]. Dystroglycan localizes to OL adhesion contact sites, and co-precipitates with focal adhesion kinase [48]. Recent work has also shown that nestin-Cre driven deletion of dystroglycan negatively impacts cerebellar granule neuron migration [49], offering a parallel function for dystroglycan in OPCs, as neurons and OLs share much of the same migratory mechanisms [50]. The role of dystroglycan (and/or other Ln adhesion molecules) in OPC migration remains an open question for investigation, and may provide an explanation for the migration-permissive character of Ln.

In contrast to Ln, for which α6β1 is the exclusive integrin receptor, OPCs express the Fn-sensitive αvβ1, αvβ3, αvβ5 and αvβ8 integrins [18]. With regard to our work, αvβ3 and αvβ1 are most relevant, as ILK exclusively binds β1 and β3 cytosolic tails [19, 20]. [39] previously demonstrated a role for αvβ3 in OPC migration on Fn, while, in contrast, αvβ1 was determined dispensable. A role for β1 integrin in OPC migration on Fn was suggested by Tiwari-Woodruff and colleagues in 2001, although in their study, migration was assessed after 4 days in vitro, a point at which OPC proliferation may confound observations. Rather, in line with [39], we favor the concept that the migratory phenotype manifested by Ilk / OPCs on Fn is primarily a product of perturbed signaling/stability at Fn-αvβ3-actin connections. Importantly, this does not discount a role for αvβ1 integrin in OPC migration in a broader context, as this receptor significantly mediates OPC migration on astrocyte-produced ECM [37], a substrate surely composed of various integrin ligands. Ilk / OPCs were not completely ablated in their ability to migrate on Fn, suggesting that receptors other than αvβ3 and αvβ1 may be at play. Of note, [39] previously found no role for αvβ5 in OPC migration on Fn, leaving the less-characterized αvβ8 integrin receptor with a possible function in this process [37].

In contrast to Ln and Fn that bind specific receptors on the cell surface, the adhesion of cells to PDL is mediated by charge interactions between anionic membrane domains and the positively charged nature of polylysine [40]. Polylysine is not thought to engage integrins, although it is capable of binding ECM proteins present in cell culture media [42]. We propose the impaired migration of Ilk / OPCs on PDL is a result of this latter phenomenon, where ILK-devoid cells are compromised in their ability to engage PDL-immobilized ligands contributed by the media. Fetal bovine serum, which makes up 10 % of our migration media, is known to contain the ECM protein vitronectin. Similar to Fn, vitronectin also possesses the arginine-glycine-aspartic acid (RGD) motif recognized by many integrin receptors [51]. In fact, vitronectin is believed to be the major cell-attachment protein present in fetal bovine serum [52]. OLs express αvβ1, αvβ3, αvβ5 and αvβ8 integrins, which all possess affinity for vitronectin [5356]. As ILK only binds β1 and β3 integrins, we can speculate that defective migration of Ilk / OPCs on PDL is caused partly by the reduced stability of αvβ1, αvβ3 integrin adhesions responsible for stabilizing connections between vitronectin and the cytoskeleton.

Cell signaling in OPC migration and relevance to MS therapy development

Oligodendrocyte precursor cells (OPCs) migrate extensively prior to the onset of central nervous system (CNS) myelination [57] a process governed in part by the extracellular matrix (ECM) during both normal development and remyelination of demyelinated lesions [58]. Endogenous lesion repair in MS decreases with disease progression, a consequence of reduced OPC proliferation, differentiation and/or migration [3]. Of note, OPCs accumulate at the periphery of early MS lesions [59], which is thought to be a result of lesion-derived inhibitory factors impeding OPC recruitment inwards [6064]. Elucidating the molecular mechanisms that govern OPC migration will therefore facilitate the design of therapeutics aimed at promoting OPC infiltration into MS lesions.

We have previously shown that ILK-devoid OLs possess elevated RhoA activity, a phenomenon associated with a disorganized actin cytoskeleton [25]. This observation agrees with previous work from other cell systems [65, 66]; reviewed by [21, 22], where ILK loss leads to an upregulation in RhoA activity, while concomitantly reducing cell–matrix adhesions [67]. Conversely, reducing RhoA activity promotes reorganization of focal contacts [68], and diminishes actomyosin contractility to facilitate migration (reviewed by [69]. It is quite likely then, that an ideal level of RhoA activity exists that promotes persistent directional migration when properly localized subcellularly. In such a case, localized RhoA activity would promote cell migration by preventing the extension of numerous leading lamellipodia, ensuring focal contacts remain dynamic and by controlling the cleavage of trailing-edge adhesions. If Ilk / OPCs do suffer from elevated RhoA activity, the dysregulation of these cellular processes could explain their compromised migratory capacity. While we did not test this hypothesis, it is an intriguing direction for future research.

The RhoA signaling axis is becoming of increasing interest with regard to MS therapeutics. Other proteins such as Netrin-1, Slit2 and NG2 mediate OPC migration through modulation of RhoA signaling [7072]. RhoA pathway downregulation by pharmacological means enhances morphological development of OL-lineage cells [25, 73, 74], even in the presence of OL-inhibitory factors [75, 76]. Blockade of LINGO-1, an upstream regulator of RhoA (reviewed by [77], not only facilitates OL differentiation in vitro [78] but also enhances remyelination in vivo [79]. As multiple signaling pathways converge on RhoA to regulate OL biology, as well as the fact that RhoA-ROCK pathway inhibitors are currently in use for other CNS ailments [80], their efficacy in promoting remyelination in MS disease models remains an appealing direction for future investigation.

Conclusions

Here, we present a new OPC migration assay tailored specifically for use with mouse-derived cells, which we name the OPCA assay. OPCAs are highly enriched for OPCs, and when seeded onto Ln, Fn or polylysine, rapid outward migration occurs. We further show that the OPCA method is amenable to conditional gene ablation through use of TAT-Cre recombinase to deplete ILK from OPCAs generated from Ilk fl/fl mice. ILK-devoid OPCs were heavily impaired at migrating on Fn or polylysine matrices, while only mildly delayed in their migration on Ln. Inclusively, our work identifies ILK as a player in OPC migration, and provides a new tool for the study of mouse OPC motility in vitro.

Declarations

Authors’ contributions

RWO developed the OPC migration assay, performed all of the studies, participated in the analysis, performed the statistical analysis and drafted the manuscript. SEC and JPM helped perform some of the experiments. RK participated in the design of the study and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors would like to thank Dr. René St-Arnaud and Dr. Steffany Bennett for generous donation of transgenic mice. We also thank Dr. William Stallcup for providing the PDGFR-α antibody. This work was supported by a grant to RK from the Multiple Sclerosis Society of Canada. RWO and JPM are both recipients of the Frederick Banting and Charles Best Canadian Institutes of Health Research Doctoral Award, SEC is a recipient of an Ontario Graduate Scholarship and RK is a recipient of a University Health Research Chair from the University of Ottawa.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Ottawa Hospital Research Institute
(2)
Department of Cellular and Molecular Medicine, University of Ottawa
(3)
Department of Medicine, University of Ottawa
(4)
University of Ottawa Centre for Neuromuscular Disease

References

  1. Snaidero N, Möbius W, Czopka T, Hekking LHP, Mathisen C, Verkleij D, Goebbels S, Edgar J, Merkler D, Lyons DA, Nave K-A, Simons M. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell. 2014;156:277–90.View ArticlePubMedGoogle Scholar
  2. Noll E, Miller RH. Oligodendrocyte precursors originate at the ventral ventricular zone dorsal to the ventral midline region in the embryonic rat spinal cord. Development. 1993;118:563–73.PubMedGoogle Scholar
  3. Keough MB, Yong VW. Remyelination therapy for multiple sclerosis. Neurotherapeutics. 2013;10:44–54.PubMed CentralView ArticlePubMedGoogle Scholar
  4. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 1980;85:890–902.View ArticlePubMedGoogle Scholar
  5. Avellana-Adalid V, Nait-Oumesmar B, Lachapelle F, Baron-Van Evercooren A. Expansion of rat oligodendrocyte progenitors into proliferative “oligospheres” that retain differentiation potential. J Neurosci Res. 1996;45:558–70.View ArticlePubMedGoogle Scholar
  6. Stallcup WB, Beasley L. Bipotential glial precursor cells of the optic nerve express the NG2 prtoglycan. J Neurosci. 1987;7(9):2737–44.PubMedGoogle Scholar
  7. Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J, Lu QR. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc. 2007;2:1044–51.View ArticlePubMedGoogle Scholar
  8. Horiuchi M, Lindsten T, Pleasure D, Itoh T. Differing in vitro survival dependency of mouse and rat NG2 + oligodendroglial progenitor cells. J Neurosci Res. 2010;88:957–70.PubMed CentralPubMedGoogle Scholar
  9. O’Meara RW, Ryan SD, Colognato H, Kothary R. Derivation of enriched oligodendrocyte cultures and oligodendrocyte/neuron myelinating co-cultures from post-natal murine tissues. J Vis Exp. 2011.Google Scholar
  10. Pedraza CE, Monk R, Lei J, Hao Q, Macklin WB. Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors. Glia. 2008;56:1339–52.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Vitry S, Avellana-Adalid V, Hardy R, Lachapelle F, Barone-Van Evercooren A. Mouse oligospheres: from pre-progenitors to functional oligodendrocytes. J Neurosci Res. 1999;58(6):735–51.View ArticlePubMedGoogle Scholar
  12. Frost EE, Milner R, Ffrench-Constant C. Migration assays for oligodendrocyte precursor cells. Methods in molecular biology. 2000;139:265–78.PubMedGoogle Scholar
  13. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962;115:453–66.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Varani J, Orr W, Ward PA. A comparison of the migration patterns of normal and malignant cells in two assay systems. Am J Pathol. 1978;90:159–72.PubMed CentralPubMedGoogle Scholar
  15. Terpstra L, Prud’homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, St-Arnaud R. Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol. 2003;162:139–48.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis. 2007;2000(45):593–605.View ArticleGoogle Scholar
  17. Nishiyama A, Komitova M, Suzuki R, Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci. 2009;10:9–22.View ArticlePubMedGoogle Scholar
  18. Milner R, Ffrench-Constant C. A developmental analysis of oligodendroglial integrins in primary cells: changes in alpha v-associated beta subunits during differentiation. Development. 1994;120:3497–506.PubMedGoogle Scholar
  19. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature. 1996;379:91–6.View ArticlePubMedGoogle Scholar
  20. Pasquet J-M, Noury M, Nurden AT. Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway. Thromb Haemost. 2002;88:115–22.PubMedGoogle Scholar
  21. Ghatak S, Morgner J, Wickström SA. ILK: a pseudokinase with a unique function in the integrin-actin linkage. Biochem Soc Trans. 2013;41:995–1001.View ArticlePubMedGoogle Scholar
  22. Wickström SA, Lange A, Montanez E, Fässler R. The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase. EMBO J. 2010;29:281–91.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Legate KR, Montañez E, Kudlacek O, Fässler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol. 2006;7:20–31.View ArticlePubMedGoogle Scholar
  24. Chun SJ, Rasband MN, Sidman RL, Habib AA, Vartanian T. Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J Cell Biol. 2003;163:397–408.PubMed CentralView ArticlePubMedGoogle Scholar
  25. O’Meara RW, Michalski J-P, Anderson C, Bhanot K, Rippstein P, Kothary R. Integrin-linked kinase regulates process extension in oligodendrocytes via control of actin cytoskeletal dynamics. J Neurosci. 2013;33:9781–93.View ArticlePubMedGoogle Scholar
  26. Wewer UM, Engvall E. Merosin/laminin-2 and muscular dystrophy. Neuromuscul Disord. 1996;6:409–18.View ArticlePubMedGoogle Scholar
  27. Decker L, ffrench-Constant C. Lipid rafts and integrin activation regulate oligodendrocyte survival. J Neurosci. 2004;24:3816–25.View ArticlePubMedGoogle Scholar
  28. Laursen LS, Chan CW, ffrench-Constant C. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J Neurosci. 2009;29:9174–85.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Buttery P, Ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendocytes. Mol Cell Neurosci. 1999;14:199–212.View ArticlePubMedGoogle Scholar
  30. Colognato H, Baron W, Avellana-Adalid V, Relvas JB, Baron-Van Evercooren A, Georges-Labouesse E, ffrench-Constant C. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol. 2002;4:833–41.View ArticlePubMedGoogle Scholar
  31. Morissette N, Carbonetto S. Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. J Neurosci. 1995;15:8067–82.PubMedGoogle Scholar
  32. Zhao C, Fancy SPJ, Franklin RJM, ffrench-Constant C. Up-regulation of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination. J Neurosci Res. 2009;87:3447–55.View ArticlePubMedGoogle Scholar
  33. Colognato H, Tzvetanova ID. Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia. Developmental neurobiology. 2011;71:924–55.View ArticlePubMedGoogle Scholar
  34. Frost E, Kiernan BW, Faissner A, ffrench-Constant C. Regulation of oligodendrocyte precursor migration by extracellular matrix: evidence for substrate-specific inhibition of migration by tenascin-C. Dev Neurosci. 1996;18:266–73.View ArticlePubMedGoogle Scholar
  35. Niehaus A, Stegmüller J, Diers-Fenger M, Trotter J. Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration. J Neurosci. 1999;19:4948–61.PubMedGoogle Scholar
  36. Schmidt C, Ohlemeyer C, Labrakakis C, Walter T, Kettenmann H, Schnitzer J. Analysis of motile oligodendrocyte precursor cells in vitro and in brain slices. Glia. 1997;20:284–98.View ArticlePubMedGoogle Scholar
  37. Milner R, Edwards G, Streuli C, Ffrench-Constant C. A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors. J Neurosci. 1996;16:7240–52.PubMedGoogle Scholar
  38. Stoffels JMJ, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, Ffrench-Constant C, Franklin RJM, Hoekstra D, Zhao C, Baron W. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain. 2013;136:116–31.View ArticlePubMedGoogle Scholar
  39. Gudz TI, Komuro H, Macklin WB. Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex. J Neurosci. 2006;26:2458–66.View ArticlePubMedGoogle Scholar
  40. Mazia D, Schatten G, Sale W. Adhesion of cells to surfaces coated with polylysine. Applications to electron microscopy. J Cell Biol. 1975;66:198–200.View ArticlePubMedGoogle Scholar
  41. Machesky LM, Hall A. Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization. J Cell Biol. 1997;138:913–26.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Mao X, Peng H, Ling J, Friis T, Whittaker AK, Crawford R, Xiao Y. Enhanced human bone marrow stromal cell affinity for modified poly(L-lactide) surfaces by the upregulation of adhesion molecular genes. Biomaterials. 2009;30:6903–11.View ArticlePubMedGoogle Scholar
  43. Decker L, Avellana-Adalid V, Nait-Oumesmar B, Durbec P, Baron-Van Evercooren A. Oligodendrocyte precursor migration and differentiation: combined effects of PSA residues, growth factors, and substrates. Mol Cell Neurosci. 2000;16:422–39.View ArticlePubMedGoogle Scholar
  44. Amberger VR, Avellana-Adalid V, Hensel T, Baron-Van Evercooren A, Schwab ME. Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin. Eur J Neurosci. 1997;9(1):151–62.View ArticlePubMedGoogle Scholar
  45. Câmara J, Wang Z, Nunes-Fonseca C, Friedman HC, Grove M, Sherman DL, Komiyama NH, Grant SG, Brophy PJ, Peterson A, Ffrench-Constant C. Integrin-mediated axoglial interactions initiate myelination in the central nervous system. J Cell Biol. 2009;185:699–712.PubMed CentralView ArticlePubMedGoogle Scholar
  46. Lee KK, De Repentigny Y, Saulnier R, Rippstein P, Macklin WB, Kothary R. Dominant-negative beta1 integrin mice have region-specific myelin defects accompanied by alterations in MAPK activity. Glia. 2006;53:836–44.View ArticlePubMedGoogle Scholar
  47. Colognato H, Galvin J, Wang Z, Relucio J, Nguyen T, Harrison D, Yurchenco PD, Ffrench-Constant C. Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination. Development. 2007;134:1723–36.View ArticlePubMedGoogle Scholar
  48. Eyermann C, Czaplinski K, Colognato H. Dystroglycan promotes filopodial formation and process branching in differentiating oligodendroglia. J Neurochem. 2012;120:928–47.PubMedGoogle Scholar
  49. Nguyen H, Ostendorf AP, Satz JS, Westra S, Ross-Barta SE, Campbell KP, Moore SA. Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins. Acta Neuropathol Commun. 2013;1:58.PubMed CentralView ArticlePubMedGoogle Scholar
  50. De Castro F, Bribián A. The molecular orchestra of the migration of oligodendrocyte precursors during development. Brain Res Brain Res Rev. 2005;49:227–41.View ArticlePubMedGoogle Scholar
  51. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697–715.View ArticlePubMedGoogle Scholar
  52. Hayman EG, Pierschbacher MD, Suzuki S, Ruoslahti E. Vitronectin—a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res. 1985;160(2):245–58.View ArticlePubMedGoogle Scholar
  53. Bodary SC, McLean JW. The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem. 1990;265:5938–41.PubMedGoogle Scholar
  54. Nishimura SL, Sheppard D, Pytela R. Integrin alpha v beta 8. Interaction with vitronectin and functional divergence of the beta 8 cytoplasmic domain. J Biol Chem. 1994;269(28):708–15.Google Scholar
  55. Pytela R, Pierschbacher MD, Ruoslahti E. A 125.115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci USA. 1985;82:5766–70.PubMed CentralView ArticlePubMedGoogle Scholar
  56. Wayner EA, Orlando RA, Cheresh DA. Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol. 1991;113(4):919–29.View ArticlePubMedGoogle Scholar
  57. De Castro F, Bribián A, Ortega MC. Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology. Cell Mol Life Sci. 2013;70:4355–68.View ArticlePubMedGoogle Scholar
  58. Lau LW, Cua R, Keough MB, Haylock-Jacobs S, Yong VW. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci. 2013;14:722–9.View ArticlePubMedGoogle Scholar
  59. Kuhlmann T, Miron V, Cui Q, Cuo Q, Wegner C, Antel J, Brück W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain. 2008;131:1749–58.View ArticlePubMedGoogle Scholar
  60. Bin JM, Rajasekharan S, Kuhlmann T, Hanes I, Marcal N, Han D, Rodrigues SP, Leong SY, Newcombe J, Antel JP, Kennedy TE. Full-length and fragmented netrin-1 in multiple sclerosis plaques are inhibitors of oligodendrocyte precursor cell migration. Am J Pathol. 2013;183:673–80.View ArticlePubMedGoogle Scholar
  61. Boyd A, Zhang H, Williams A. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol. 2013;125:841–59.PubMed CentralView ArticlePubMedGoogle Scholar
  62. Clemente D, Ortega MC, Arenzana FJ, de Castro F. FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions. J Neurosci. 2011;31:14899–909.View ArticlePubMedGoogle Scholar
  63. Sobel RA, Ahmed AS. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis. J Neuropathol Exp Neurol. 2001;60:1198–207.View ArticlePubMedGoogle Scholar
  64. Williams A, Piaton G, Aigrot M-S, Belhadi A, Théaudin M, Petermann F, Thomas J-L, Zalc B, Lubetzki C. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain. 2007;130:2554–65.View ArticlePubMedGoogle Scholar
  65. Blumbach K, Zweers MC, Brunner G, Peters AS, Schmitz M, Schulz J-N, Schild A, Denton CP, Sakai T, Fässler R, Krieg T, Eckes B. Defective granulation tissue formation in mice with specific ablation of integrin-linked kinase in fibroblasts—role of TGFβ1 levels and RhoA activity. J Cell Sci. 2010;123:3872–83.View ArticlePubMedGoogle Scholar
  66. Kogata N, Tribe RM, Fässler R, Way M, Adams RH. Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction. Genes Dev. 2009;23:2278–83.PubMed CentralView ArticlePubMedGoogle Scholar
  67. Elad N, Volberg T, Patla I, Hirschfeld-Warneken V, Grashoff C, Spatz JP, Fässler R, Geiger B, Medalia O. The role of integrin-linked kinase in the molecular architecture of focal adhesions. J Cell Sci. 2013;126:4099–107.View ArticlePubMedGoogle Scholar
  68. Lavelin I, Wolfenson H, Patla I, Henis YI, Medalia O, Volberg T, Livne A, Kam Z, Geiger B. Differential effect of actomyosin relaxation on the dynamic properties of focal adhesion proteins. PLoS One. 2014;9(2):e90269.View ArticleGoogle Scholar
  69. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996;84:359–69.View ArticlePubMedGoogle Scholar
  70. Binamé F, Sakry D, Dimou L, Jolivel V, Trotter J. NG2 regulates directional migration of oligodendrocyte precursor cells via Rho GTPases and polarity complex proteins. J Neurosci. 2013;33:10858–74.View ArticlePubMedGoogle Scholar
  71. Liu X, Lu Y, Zhang Y, Li Y, Zhou J, Yuan Y, Gao X, Su Z, He C. Slit2 regulates the dispersal of oligodendrocyte precursor cells via Fyn/RhoA signaling. J Biol Chem. 2012;287:17503–16.PubMed CentralView ArticlePubMedGoogle Scholar
  72. Rajasekharan S, Bin JM, Antel JP, Kennedy TE. A central role for RhoA during oligodendroglial maturation in the switch from netrin-1-mediated chemorepulsion to process elaboration. J Neurochem. 2010;113:1589–97.PubMedGoogle Scholar
  73. Liang X, Draghi NA, Resh MD. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci. 2004;24:7140–9.View ArticlePubMedGoogle Scholar
  74. Wolf RM, Wilkes JJ, Chao MV, Resh MD. Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte differentiation. J Neurobiol. 2001;49:62–78.View ArticlePubMedGoogle Scholar
  75. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, Franklin RJM, Altmann F, Lubec G, Kotter MR. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain. 2009;132:465–81.PubMed CentralView ArticlePubMedGoogle Scholar
  76. Siebert JR, Osterhout DJ. The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. J Neurochem. 2011;119:176–88.View ArticlePubMedGoogle Scholar
  77. Mi S, Pepinsky RB, Cadavid D. Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic. CNS Drugs. 2013;27:493–503.View ArticlePubMedGoogle Scholar
  78. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci. 2005;8:745–51.View ArticlePubMedGoogle Scholar
  79. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJM, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol. 2009;65:304–15.View ArticlePubMedGoogle Scholar
  80. Chen M, Liu A, Ouyang Y, Huang Y, Chao X, Pi R. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders? Expert Opin Investig Drugs. 2013;22:537–50.View ArticlePubMedGoogle Scholar

Copyright

© O’Meara et al. 2016

Advertisement